Vlahos L, Dimakakos P, Moulopoulou A, Drivas G, Keysser R, Papavasiliou C
Department of Radiology, University of Athens, Areteion University Hospital.
Radiologe. 1987 Dec;27(12):581-2.
A double-blind clinical trial was performed on 50 patients in order to compare omnipague (iohexol) and Ultravist-300 (iopromide) for peripheral arteriography. Both contrast media were well tolerated, but there was less body heat and pain in the Ultravist group. There were no idiosyncratic reactions or significant changes in blood pressure before and after the injection.
为比较欧乃派克（碘海醇）和优维显-300（碘普罗胺）在外周动脉造影中的效果，对50名患者进行了一项双盲临床试验。两种造影剂耐受性均良好，但优维显组的身体发热和疼痛较少。注射前后均未出现特异反应或血压显著变化。
